Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Semaglutide accounts for the top spot in the oral GLP-1 agonist space, owing to its excellent clinical efficacy in both lowering blood glucose levels and weight reduction, as well as its relatively early entry to the oral formulations market
For patients not on an antihyperglycemic agent at study entry, mean reductions from baseline in A1C were: sitagliptin 100 mg once daily, -1.1%
Prices and offers mentioned in this article are subject to change at any time
Instead of following a standard rapid-escalation schedule, our clinical protocol focuses on identifying a dose that provides meaningful health benefits, while being specifically designed to minimize side effects so you can maintain your quality of life
US$ 26.82
US$ 26.89
US$ 29.51
US$ 22.84
